Universitätskrankenhaus Hamburg-Eppendorf
Hamburg, 20246, Germany
NCT Number: NCT03768752
Sepsis is one of the most challenging conditions with an exceptionally high mortality rate. Diastolic Dysfunction is common in septic patients and has been found to be associated with mortality. However, the reasons for this remain unclear. Therefore, the goal of this study is to investigate diastolic dysfunction in septic patients on the intensive care unit. Special attention is paid to the presence of lung edema and general edema as a potential link between diastolic dysfunction and elevated mortality in septic patients. During the septic phase daily ultrasound examinations of heart and lung will be performed as to monitor diastolic function and lung edema.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Hamburg, 20246, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: While in septic condition, up to 10 days maximum.
Diastolic Dysfunction specified by echocardiographic doppler derived mitral inflow pattern and tissue doppler derived diastolic mitral annular velocities (E/E').
Time frame: While in septic condition, up to 10 days maximum.
Pulmonary edema specified by B line ultrasound score (Lung ultrasound protocol for the assessment of pulmonary fluid status according to Enghardt et al. 2015).
Universitätsklinikum Hamburg-Eppendorf
Other
Left Ventricular Diastolic Dysfunction as a Risk Factor for Interstitial Lung Edema in Septic Patients on the Intensive Care Unit
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02679625
Edema, Fluid Overload
Sylmar, California, United States
View Trial DetailsNCT07656428
Cardiovascular Diseases, Digestive System Diseases
Taipei, Taiwan
View Trial DetailsNCT06626984
Edema, Endothelial Dysfunction
View Trial DetailsNCT06572995
Edema, Fluid Overload
Brest, France
View Trial Details